Notice of Clarification to PAR-09-016, Innovation in Molecular Imaging Probes (R01) |
NOT-EB-09-001 |
|
|
Notice of Clarification Regarding Submissions to PAR-16-116 "Bioengineering Research Partnerships (U01)" |
NOT-EB-16-006 |
|
|
Notice of Clarification Regarding Participant Costs for PAR-23-114, "Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)" |
NOT-EB-23-009 |
|
|
Notice of Clarification of the Device Requirement for RFA-NS-17-005 "BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3)" |
NOT-NS-18-004 |
|
|
Notice of Clarification of the Device Requirement for "BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44)" |
NOT-NS-18-006 |
|
|
Notice of Clarification of Research Areas Included in PAR-16-106 Rapid Assessment of Zika Virus (ZIKV) Complications (R21) |
NOT-NS-16-027 |
|
|
Notice of Clarification of Product Integrity Information in PA-18-817 "Administrative Supplements for Research on Dietary Supplements (Admin Supp - Clinical Trial Not Allowed)" |
NOT-OD-19-145 |
|
|
Notice of Clarification of NIH BRAIN Initiative Institutional Letter for RFA-NS-19-043 and RFA-NS-19-044" K99/R00 - BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity" |
NOT-NS-20-094 |
|
|
Notice of Clarification of NIH BRAIN Initiative Institutional Letter for RFA-MH-23-330 and RFA-MH-23-331 K99/R00 - BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity |
NOT-MH-23-345 |
|
|
Notice of Clarification of Eligibility Regarding Foreign Components for PAR-20-084, "NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)" |
NOT-EB-22-004 |
|
|